Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000001169 | SCV001139575 | pathogenic | Hereditary spastic paraplegia 11 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
DASA | RCV000001169 | SCV002061250 | pathogenic | Hereditary spastic paraplegia 11 | 2022-01-05 | criteria provided, single submitter | clinical testing | The c.529_533del;p.(Ile177Serfs*2) is a null frameshift variant (NMD) in the SPG11 gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevantexon to the transcript -PVS1. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 1110; OMIM: 610844.0002; PMID: 26556829; 19105190; 17322883) - PS4. The variant is present at low allele frequencies population databases (rs312262716– gnomAD 0.0006568%; ABraOM 0.000427 frequency - http://abraom.ib.usp.br/) - PM2_supporting. The p.(Ile177Serfs*2) was detected in trans with a pathogenic variant (PMID: 26556829; 19105190) - PM3. The variant co-segregated with disease in multiple affected family members (PMID: 26556829; 19105190) - PP1. In summary, the currently available evidence indicates that the variant is pathogenic. |
Labcorp Genetics |
RCV000001169 | SCV002194060 | pathogenic | Hereditary spastic paraplegia 11 | 2024-02-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile177Serfs*2) in the SPG11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG11 are known to be pathogenic (PMID: 19105190, 20110243, 22154821, 26556829). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with hereditary spastic paraplegia (PMID: 17322883). ClinVar contains an entry for this variant (Variation ID: 1110). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV000001169 | SCV002762892 | pathogenic | Hereditary spastic paraplegia 11 | criteria provided, single submitter | clinical testing | ||
Gene |
RCV004719605 | SCV005326139 | pathogenic | not provided | 2023-06-12 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19105190, 22696581, 29946510, 26556829, 17322883, 33059505) |
OMIM | RCV000001169 | SCV000021319 | pathogenic | Hereditary spastic paraplegia 11 | 2015-11-10 | no assertion criteria provided | literature only | |
Gene |
RCV000001169 | SCV000058160 | not provided | Hereditary spastic paraplegia 11 | no assertion provided | literature only | ||
OMIM | RCV000202378 | SCV000257389 | pathogenic | Charcot-Marie-Tooth disease axonal type 2X | 2015-11-10 | no assertion criteria provided | literature only |